(Q42247695)

19 October 2017

The withdrawal of benztropine mesylate in chronic schizophrenic patients (English)

1 reference

19 October 2017

The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

8 October 2023

0 references

L. A. Baker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362765

8 October 2023

L. Y. Cheng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362765

8 October 2023

I. B. Amara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362765

8 October 2023

language of work or name

English

0 references

publication date

1 December 1983

1 reference

full work available at URL

19 October 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000201323

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

British Journal of Psychiatry

8 October 2023

published in

1 reference

19 October 2017

143

1 reference

19 October 2017

584-590

1 reference

Do Anticholinergics Antagonize Antipsychotic Drug Action?

19 October 2017

1

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

8 October 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug

8 October 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

A rating scale for extrapyramidal side effects

8 October 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients.

8 October 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic Schizophrenics

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

The Structure of the Wechsler Memory Scale and its Relationship to ‘Brain Damage’

8 October 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Protracted vomiting following abrupt cessation of psychotropics: a case report

8 October 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

NOSIE-30: A Treatment-Sensitive Ward Behavior Scale

8 October 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Atropine coma: a somatic therapy in psychiatry

8 October 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study

8 October 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Reversal of central anticholinergic syndrome in man by physostigmine

8 October 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Human memory and the cholinergic system. A relationship to aging?

8 October 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Memory and cognitive function in man: Does the cholinergic system have a specific role?

8 October 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Antiparkinson Drug Overuse

8 October 2023

25

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Antiparkinsonian agents and depot phenothiazine

8 October 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Changes in cognition, attention and language in acute schizophrenia

8 October 2023

31

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

An Inventory for Measuring Depression

8 October 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

8 October 2023

Benztropine psychosis

34

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Central nervous system effects of hyoscine in man

8 October 2023

35

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy

8 October 2023

36

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis

8 October 2023

37

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs

8 October 2023

39

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Flexible System for the Diagnosis of Schizophrenia: Report from the WHO International Pilot Study of Schizophrenia

8 October 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Confusional Episodes and Antidepressant Medication

8 October 2023

41

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Cognitive functions in manic-depressives: effects of lithium and physostigmine

8 October 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Central atropine-like toxicity in combined psychotropic drug administration

8 October 2023

45

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism

8 October 2023

47

1 reference

https://api.crossref.org/works/10.1192/BJP.143.6.584

8 October 2023

Identifiers

1 reference

release_ptjtorpqcrhifktbymvy24gc3q

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ptjtorpqcrhifktbymvy24gc3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference